Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma

被引:53
作者
Cvirn, G
Gallistl, S
Rehak, T
Jürgens, G
Muntean, W
机构
[1] Karl Franzens Univ Graz, Inst Med Chem, A-8010 Graz, Austria
[2] Karl Franzens Univ Graz, Pregl Lab, A-8010 Graz, Austria
[3] Karl Franzens Univ Graz, Dept Pediat, Ludwig Boltzmann Res Inst Pediat Hemostasis & Thr, Graz, Austria
[4] Graz Univ, Dept Pediat, Graz, Austria
关键词
thrombomodulin; activated protein C; tissue factor pathway inhibitor; antithrombin; thrombin potential;
D O I
10.1046/j.1538-7836.2003.00320.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinically observed excellent hemostasis in neonates despite low levels of clotting factors is not completely understood so far. Therefore, we investigated whether physiological low levels of the inhibitor protein C (PC) facilitate thrombin formation in tissue factor (TF)-activated plasma samples. PC was activated by endogenously generated thrombin after addition of soluble thrombomodulin (TM). The capability of activated PC (APC) to suppress thrombin formation was significantly more pronounced in adult than in cord plasma. Addition of 4 nm of TM decreased the thrombin potential (TP) in cord plasma by 10%, and in adult plasma by 52% in the presence of 5 pm TF. We demonstrate that this low anticoagulant action of PC is attributable to the low levels of tissue factor pathway inhibitor (TFPI) and antithrombin (AT) physiologically present in cord plasma. Addition of 4 nM TM decreased the TP by 58% in cord plasma adjusted to contain TFPI and AT at adult levels in the presence of 5 pm TF. Thus, the combined low anticoagulant action of the three inhibitors APC, TFPI, and AT in cord plasma allows enhanced thrombin formation associated with shorter clotting times compared with adult plasma when low amounts of TF are applied to initiate clot formation. Although our laboratory experiments do not allow definite conclusions for various clinical situations, our data might contribute to explain excellent hemostasis in neonates despite low levels of procoagulants.
引用
收藏
页码:1785 / 1790
页数:6
相关论文
共 25 条
[1]  
ANDREW M, 1990, THROMB HAEMOSTASIS, V63, P27
[2]   DEVELOPMENT OF THE HUMAN COAGULATION SYSTEM IN THE FULL-TERM INFANT [J].
ANDREW, M ;
PAES, B ;
MILNER, R ;
JOHNSTON, M ;
MITCHELL, L ;
TOLLEFSEN, DM ;
POWERS, P .
BLOOD, 1987, 70 (01) :165-172
[3]  
ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95
[4]   Normal thrombin generation [J].
Butenas, S ;
van't Veer, C ;
Mann, KG .
BLOOD, 1999, 94 (07) :2169-2178
[5]   Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates [J].
Cvirn, G ;
Gallistl, S ;
Leschnik, B ;
Muntean, W .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (02) :263-268
[6]  
DAVID M, 1994, J PEDIATR, V124, P831
[7]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[8]   THROMBOMODULIN - BIOLOGY AND POTENTIAL CARDIOVASCULAR APPLICATIONS [J].
DITTMAN, WA .
TRENDS IN CARDIOVASCULAR MEDICINE, 1991, 1 (08) :331-336
[9]   THE REGULATION OF NATURAL ANTICOAGULANT PATHWAYS [J].
ESMON, CT .
SCIENCE, 1987, 235 (4794) :1348-1352
[10]   THROMBOMODULIN AS A MODEL OF MOLECULAR MECHANISMS THAT MODULATE PROTEASE SPECIFICITY AND FUNCTION AT THE VESSEL SURFACE [J].
ESMON, CT .
FASEB JOURNAL, 1995, 9 (10) :946-955